IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

KLP Enterprises, LLC

Q3 2018 Holdings

Filed 2018-11-13 | 1 holdings | $3.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Celldex Therapeutics, Inc.COM15117B103$3.1K6,865,000100.0%